Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tracking Cancer Evolution through the Disease Course
Chris Bailey, James R. Black, James L. Reading, et al.
Cancer Discovery (2021) Vol. 11, Iss. 4, pp. 916-932
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03)
Michael Gnant, Amylou C. Dueck, Sophie Frantal, et al.
Journal of Clinical Oncology (2021) Vol. 40, Iss. 3, pp. 282-293
Open Access | Times Cited: 173
Antibodies against endogenous retroviruses promote lung cancer immunotherapy
Kevin W. Ng, Jesse Boumelha, Katey S.S. Enfield, et al.
Nature (2023) Vol. 616, Iss. 7957, pp. 563-573
Open Access | Times Cited: 159
The evolution of non-small cell lung cancer metastases in TRACERx
Maise Al Bakir, Ariana Huebner, Carlos Martínez‐Ruiz, et al.
Nature (2023) Vol. 616, Iss. 7957, pp. 534-542
Open Access | Times Cited: 128
Heterogeneity of the tumor immune microenvironment and its clinical relevance
Qingzhu Jia, Aoyun Wang, Yixiao Yuan, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 126
Genomic–transcriptomic evolution in lung cancer and metastasis
Carlos Martínez‐Ruiz, James R. Black, Clare Puttick, et al.
Nature (2023) Vol. 616, Iss. 7957, pp. 543-552
Open Access | Times Cited: 120
Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives
Yan Peng, Wuxuan Mei, Kaidong Ma, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 108
Towards precision oncology with patient-derived xenografts
Eugenia R. Zanella, Elena Grassi, Livio Trusolino
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 11, pp. 719-732
Closed Access | Times Cited: 87
Senescence and the tumor-immune landscape: Implications for cancer immunotherapy
Loretah Chibaya, Jarin T. Snyder, Marcus Ruscetti
Seminars in Cancer Biology (2022) Vol. 86, pp. 827-845
Open Access | Times Cited: 84
Lymphocyte networks are dynamic cellular communities in the immunoregulatory landscape of lung adenocarcinoma
Giorgio Gaglia, Megan L. Burger, Cecily C. Ritch, et al.
Cancer Cell (2023) Vol. 41, Iss. 5, pp. 871-886.e10
Open Access | Times Cited: 51
The two sides of chromosomal instability: drivers and brakes in cancer
Rendy Hosea, Sharon Hillary, S. Hassan R. Naqvi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 43
Breast cancer: pathogenesis and treatments
Xin Xiong, Lewei Zheng, Yu‐Qiang Ding, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 14
New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine
Hanli Xu, Shuye Lin, Ziyun Zhou, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 7, pp. 739-776
Open Access | Times Cited: 32
Cancer Evolution: A Multifaceted Affair
Giovanni Ciriello, Luca Magnani, Sarah J. Aitken, et al.
Cancer Discovery (2023) Vol. 14, Iss. 1, pp. 36-48
Open Access | Times Cited: 27
Clinical and translational relevance of intratumor heterogeneity
Marie-Anne Goyette, Marla Lipsyc-Sharf, Kornélia Polyák
Trends in cancer (2023) Vol. 9, Iss. 9, pp. 726-737
Open Access | Times Cited: 25
Decoding the interplay between genetic and non-genetic drivers of metastasis
Panagiotis Karras, James R. Black, Nicholas McGranahan, et al.
Nature (2024) Vol. 629, Iss. 8012, pp. 543-554
Closed Access | Times Cited: 15
Redox Regulation in Cancer Cells during Metastasis
Alpaslan Tasdogan, Jessalyn M. Ubellacker, Sean J. Morrison
Cancer Discovery (2021) Vol. 11, Iss. 11, pp. 2682-2692
Open Access | Times Cited: 47
Epigenetic Alterations and Mechanisms That Drive Resistance to Targeted Cancer Therapies
Narendra Wajapeyee, Romi Gupta
Cancer Research (2021) Vol. 81, Iss. 22, pp. 5589-5595
Open Access | Times Cited: 46
The Role of Circulating Biomarkers in Lung Cancer
Sayuri Herath, Habib Sadeghi Rad, Payar Radfar, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 33
EGFR exon 20 insertion mutations and ERBB2 mutations in lung cancer: a narrative review on approved targeted therapies from oral kinase inhibitors to antibody-drug conjugates
Daniel Sentana‐Lledo, Emmeline C. Academia, Hollis Viray, et al.
Translational Lung Cancer Research (2023) Vol. 12, Iss. 7, pp. 1590-1610
Open Access | Times Cited: 20
Synergistic effects of combined immunotherapy strategies in a model of multifocal hepatocellular carcinoma
María C. Ochoa, Sandra Sánchez‐Gregorio, Carlos E. de Andrea, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 4, pp. 101009-101009
Open Access | Times Cited: 13
Circulating tumour DNA detects somatic variants contributing to spatial and temporal intra-tumoural heterogeneity in head and neck squamous cell carcinoma
Karl Payne, Peter Brotherwood, Harini Suriyanarayanan, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
The Role of Cell-Free DNA in Cancer Treatment Decision Making
András Telekes, Anna Horváth
Cancers (2022) Vol. 14, Iss. 24, pp. 6115-6115
Open Access | Times Cited: 22
Strategies for Improving the Efficacy of CAR T Cells in Solid Cancers
Jon Amund Kyte
Cancers (2022) Vol. 14, Iss. 3, pp. 571-571
Open Access | Times Cited: 19
Longitudinal deep neural networks for assessing metastatic brain cancer on a large open benchmark
Katherine E. Link, Zane Schnurman, Chris Liu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
ZACN Associated with Poor Prognosis Promotes Proliferation of Kidney Renal Clear Cell Carcinoma Cells by Inhibiting JTC801-Induced Alkaliptosis
Yifan Li, Can Li
Applied Biochemistry and Biotechnology (2025)
Closed Access
Page 1 - Next Page

Scroll to top